» Articles » PMID: 35091092

Fulminant Type 1 Diabetes After COVID-19 Vaccination

Overview
Journal Diabetes Metab
Specialty Endocrinology
Date 2022 Jan 29
PMID 35091092
Authors
Affiliations
Soon will be listed here.
Citing Articles

Type 1 diabetes mellitus following COVID-19 vaccination: a report of two cases and review of literature.

Mochizuki S, Miura J, Ucida K, Kubota R, Fujikawa H, Takagi S Diabetol Int. 2024; 15(3):577-582.

PMID: 39101197 PMC: 11291814. DOI: 10.1007/s13340-024-00695-9.


The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus.

Debuysschere C, Nekoua M, Alidjinou E, Hober D Nat Rev Endocrinol. 2024; 20(10):588-599.

PMID: 38890459 DOI: 10.1038/s41574-024-01004-9.


COVID-19 vaccines and blood glucose control: Friend or foe?.

Vena W, Pigni S, Betella N, Navarra A, Mirani M, Mazziotti G Hum Vaccin Immunother. 2024; 20(1):2363068.

PMID: 38860457 PMC: 11178329. DOI: 10.1080/21645515.2024.2363068.


COVID-19 Vaccination and Abnormal Blood Glucose Level.

Mungmunpuntipantip R, Wiwanitkit V Adv Biomed Res. 2024; 12:258.

PMID: 38192882 PMC: 10772784. DOI: 10.4103/abr.abr_195_23.


Case report: A case of fulminant type 1 diabetes mellitus after COVID-19 vaccination during treatment of advanced gastric cancer: pitfall in managing immune-related adverse events.

Tanaka T, Nagasu S, Furuta T, Gobaru M, Suzuki H, Shimotsuura Y Front Oncol. 2024; 13:1264281.

PMID: 38173838 PMC: 10762640. DOI: 10.3389/fonc.2023.1264281.


References
1.
Hollstein T, Schulte D, Schulz J, Gluck A, Ziegler A, Bonifacio E . Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report. Nat Metab. 2020; 2(10):1021-1024. DOI: 10.1038/s42255-020-00281-8. View

2.
Yasuda H, Nagata M, Moriyama H, Kobayashi H, Akisaki T, Ueda H . Development of fulminant Type 1 diabetes with thrombocytopenia after influenza vaccination: a case report. Diabet Med. 2011; 29(1):88-9. DOI: 10.1111/j.1464-5491.2011.03391.x. View

3.
Okamoto M, Okamoto M, Gotoh K, Masaki T, Ozeki Y, Ando H . Fulminant type 1 diabetes mellitus with anti-programmed cell death-1 therapy. J Diabetes Investig. 2016; 7(6):915-918. PMC: 5089956. DOI: 10.1111/jdi.12531. View

4.
Imagawa A, Hanafusa T, Awata T, Ikegami H, Uchigata Y, Osawa H . Report of the Committee of the Japan Diabetes Society on the Research of Fulminant and Acute-onset Type 1 Diabetes Mellitus: New diagnostic criteria of fulminant type 1 diabetes mellitus (2012). J Diabetes Investig. 2014; 3(6):536-9. PMC: 4015434. DOI: 10.1111/jdi.12024. View

5.
Chujo D, Kawabe A, Matsushita M, Takahashi N, Tsutsumi C, Haseda F . Distinct Phenotypes of Islet Antigen-Specific CD4+ T Cells Among the 3 Subtypes of Type 1 Diabetes. J Clin Endocrinol Metab. 2020; 105(10). DOI: 10.1210/clinem/dgaa447. View